NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) | PA 20 195

Opportunity Information: Apply for PA 20 195

The NIH Exploratory/Developmental Research Grant Program (Parent R21, Clinical Trial Not Allowed) is a discretionary NIH funding opportunity designed to help investigators launch early-stage, high-potential research ideas that are not yet ready for larger, longer-term support. It is aimed at exploratory or developmental projects where the main value is testing a new concept, generating preliminary data, or proving feasibility. NIH uses the R21 mechanism to encourage work that may be relatively high-risk or unconventional, but that could pay off by opening a new line of inquiry, producing a breakthrough, or creating something broadly useful to the research community, such as a novel technique, agent, methodology, model, or application. While the work can relate to biomedical, behavioral, or clinical research, the announcement specifically indicates that clinical trials are not allowed under this parent R21 opportunity, meaning applicants should not propose studies that meet NIH definitions of a clinical trial.

The opportunity is published by the National Institutes of Health (NIH) under Funding Opportunity Number PA 20-195, and it is categorized as a grant funding instrument. The program is associated with multiple CFDA numbers (now commonly referred to as Assistance Listing numbers), reflecting that many NIH institutes and centers can use this parent announcement to support R21 projects across a wide range of health and science areas. In practice, this parent mechanism serves as a broad entry point: investigators propose an innovative project aligned with an NIH mission area, and the appropriate NIH institute or center may consider it for funding depending on fit, priorities, and available funds.

Eligibility is broad and includes many types of organizations that might carry out research or research-related activities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant types that NIH explicitly welcomes, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal government agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This breadth signals that NIH is open to supporting innovative, early-stage research concepts from many settings, including community-linked and capacity-building institutions, as well as international organizations when appropriate.

In terms of purpose and project scope, the key theme is early and conceptual development rather than mature, fully validated programs of research. NIH expects R21 projects to explore new directions, pilot novel approaches, or rapidly test an idea that could reshape understanding or practice in a field. The mechanism is often used to establish proof-of-concept, develop or refine tools and methods, or collect the critical preliminary evidence needed to compete for larger NIH grants later (for example, an R01), without requiring that the applicant already have an extensive body of supporting data. At the same time, applications still need to be scientifically rigorous and well-justified; the difference is that NIH is explicitly allowing more uncertainty and innovation than might be acceptable under mechanisms intended for more established research programs.

Key administrative details in the source data include a creation date of May 7, 2020, the NIH agency as the sponsor, and an original closing date listed as January 7, 2025. The award ceiling and expected number of awards are not specified in the provided extract, which is common in parent announcements because actual budgets and award volumes can vary by institute/center priorities, fiscal year, and the specific aims of submitted applications. Overall, this opportunity is best understood as a flexible NIH pathway for proposing bold, early-stage research ideas that could meaningfully advance biomedical, behavioral, or clinical knowledge, while explicitly excluding clinical trial proposals under this particular parent R21 announcement.

• The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.172, 93.173, 93.213, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.846, 93.855, 93.866, 93.867, 93.879.
• This funding opportunity was created on 2020-05-07.
• Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 20 195

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: